(Reuters) - Drug-eluting stents prop open diseased arteries and emit drugs to prevent re-clogging. Use of drug-eluting stents has fallen to 69.5 percent of all stent procedures from a peak in the high 80s, according to Boston Scientific.
"We believe that Boston Scientific's drug-eluting stent sales trends will face additional uncertainty as competitive risk increases over the near term," Moody's said in a statement.
Read more at Reuters.com Bonds News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment